Lynx1 Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-702,415
| Closed | -$2.84M | – | 17 |
|
|
2023
Q4 | $2.84M | Hold |
702,415
| – | – | 1.12% | 11 |
|
|
2023
Q3 | $1.89M | Sell |
702,415
-54,594
| -7% | -$147K | 1.25% | 14 |
|
|
2023
Q2 | $7.06M | Sell |
757,009
-4,249
| -0.6% | -$39.6K | 4.63% | 8 |
|
|
2023
Q1 | $6.76M | Sell |
761,258
-22,900
| -3% | -$203K | 5.64% | 7 |
|
|
2022
Q4 | $3.91M | Buy |
784,158
+279,296
| +55% | +$1.39M | 3.38% | 10 |
|
|
2022
Q3 | $2.93M | Hold |
504,862
| – | – | 2.64% | 11 |
|
|
2022
Q2 | $2.79M | Buy |
504,862
+148,035
| +41% | +$819K | 2.38% | 10 |
|
|
2022
Q1 | $4.11M | Sell |
356,827
-52,531
| -13% | -$606K | 3.82% | 9 |
|
|
2021
Q4 | $5.19M | Buy |
+409,358
| New | +$5.19M | 4.53% | 7 |
|